ProstaLund AB announced that the product Schelin Catheter has been registered and approved for sale in Switzerland. At the same time, the company has signed a couple of distribution agreements with some distributors. The first orders will be delivered during the current quarter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.646 SEK | +17.88% | +14.13% | -60.37% |
05-31 | ProstaLund Secures Order for CoreTherm System in Austria | MT |
05-16 | ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-60.37% | 4.7M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- PLUN Stock
- News ProstaLund AB
- ProstaLund AB Announces Registration and Approval of Product Schelin Catheter for Sale in Switzerland